Document 2Jqe9dqL726QRKQanBaeoMkQb

`a =- =] |\ EE oBEmUeRRcrOOoPmEWmANmCeOaMMISSION IB ve wero ams BErNuVssBelsIAres(2020) DearJ. "Thank you for your letter, in which you raise the concems of EU textiles companies as regards the amendment of Aunex I to Regulation (EU) No 2019/1021 (the POPs Regulation) to include PFOA. its salts and PFOA-related compounds. `The Commission Delegated Regulation follows the decision of the Conference of the Parties of the Stockholm Convention. The assessment performed by the POP Review `Committee indicated that alternatives to PFOA were available for the uses in medical textiles. It was not possible for the Commission to add exemptions that re not available under the Convention. However, Article 4(2) of the POPs Regulation introduces an exemption for articles "already in use" which would apply to medical textiles produced before the date of entry into application of the PFOA listing (4 July) and not covered by o`mteheetrinegxeomftphtieonPsO.PsWCeAsdoisncu9ssJeudneiannddewtaeilwitlhel piunbtleripsrhetaactliaornifoifcattihoins sehoxretmlyp.tion in the Yours faithfully. esigned pm cep Tres Com rcsBe,BLCRUUBELGE T2911 BN conI sigined c5/a8 l2a0c73c4e0s1)croc witharil 2 alyofdcrdca)ofcompisio ction 30/563